Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II, Open-Label Dose-Finding Trial of High-Dose mRNA-1273 Booster for Lung Transplant Recipients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05280158
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:42.068657+00:00
Published At
2025-03-26T00:00:00+00:00
Record Updated At
2025-03-26
Results Posted At
2025-03-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lung Transplant Recipient", "SARS-CoV-2", "Immunosuppression"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-26"
protocolSection.identificationModule.nctId
"NCT05280158"
protocolSection.identificationModule.officialTitle
"Phase I/II, Open-Label Dose-Finding Trial of High-Dose mRNA-1273 Booster for Lung Transplant Recipients"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-03-26"

Study condition terms

  • Lung Transplant Recipient (protocolSection.conditionsModule.conditions)
  • SARS-CoV-2 (protocolSection.conditionsModule.conditions)
  • Immunosuppression (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.